80 FR 15621 - National Institute of Biomedical Imaging and Bioengineering; Notice of Closed Meetings

DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health

Federal Register Volume 80, Issue 56 (March 24, 2015)

Page Range		15621-15621
FR Document		2015-06698

Federal Register, Volume 80 Issue 56 (Tuesday, March 24, 2015)

[Federal Register Volume 80, Number 56 (Tuesday, March 24, 2015)]
[Notices]
[Page 15621]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2015-06698]



[[Page 15621]]

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute of Biomedical Imaging and Bioengineering; 
Notice of Closed Meetings

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. App.), notice is hereby given of the following 
meetings.
    The meetings will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Institute of Biomedical Imaging and 
Bioengineering Special Emphasis Panel; P41 BTRC review (2015/05).
    Date: May 27, 2015.
    Time: 9:00 a.m. to 6:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, Two Democracy Plaza, Suite 
920, 6707 Democracy Boulevard, Bethesda, MD 20892, (Virtual 
Meeting).
    Contact Person: Manana Sukhareva, Ph.D., Scientific Review 
Officer, National Institute of Biomedical Imaging and 
Bioengineering, 6707 Democracy Boulevard, Suite 959, Bethesda, MD 
20892, (301) 451-3397, [email protected].

    Name of Committee: National Institute of Biomedical Imaging and 
Bioengineering Special Emphasis Panel; 2015-10 SBIR HD Review.
    Date: June 24, 2015.
    Time: 10:00 a.m. to 6:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, Two Democracy Plaza, Suite 
920, 6707 Democracy Boulevard, Bethesda, MD 20892, (Virtual 
Meeting).
    Contact Person: Ruth Grossman, DDS, Scientific Review Officer, 
National Institute of Biomedical Imaging and Bioengineering, 
National Institute of Health, 6707 Democracy Boulevard, Rm. 960, 
Bethesda, MD 20892, (301) 496-8775, [email protected].


    Dated: March 19, 2015.
David Clary,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2015-06698 Filed 3-23-15; 8:45 am]
BILLING CODE 4140-01-P

Federal Register / Vol. 80, No. 56 / Tuesday, March 24, 2015 / Notices 15621

DEPARTMENT OF HEALTH AND DEPARTMENT OF HEALTH AND business days in advance at http://
HUMAN SERVICES HUMAN SERVICES www.cdc.gov/cancer/breast/what_cdc_is
_doing/meetings.htm. Please complete
National Institutes of Health Centers for Disease Control and all the required fields before submitting
Prevention your registration and submit no later
National Institute of Biomedical than April 14, 2015.
Imaging and Bioengineering; Notice of Advisory Committee on Breast Cancer Contact Person For More Information:
Closed Meetings in Young Women (ACBCYW) Temeika L. Fairley, Ph.D., Designated
In accordance with section 10(a)(2) of Federal Officer, National Center for
Pursuant to section 10(d) of the Chronic Disease Prevention and Health
the Federal Advisory Committee Act
Federal Advisory Committee Act, as Promotion, CDC, 4770 Buford Highway
(Pub. L. 92–463), the Centers for Disease
amended (5 U.S.C. App.), notice is NE., Mailstop K52, Atlanta, Georgia,
Control and Prevention (CDC),
hereby given of the following meetings. 30341, Telephone (770) 488–4518, Fax
announces the following meeting of the
The meetings will be closed to the aforementioned committee: (770) 488–4760 Email: acbcyw@cdc.gov.
public in accordance with the Time and Date: 1:00 p.m.–4:00 p.m. The Director, Management Analysis
provisions set forth in sections EST, April 17, 2015. and Services Office, has been delegated
552b(c)(4) and 552b(c)(6), Title 5 U.S.C., Place: This meeting is accessible by the authority to sign Federal Register
as amended. The grant applications and teleconference and web access. notices pertaining to announcements of
the discussions could disclose Teleconference and web access login meetings and other committee
confidential trade secrets or commercial information is as follows: management activities, for both the
property such as patentable material, Toll-Free Telephone: 1–800–369– Centers for Disease Control and
and personal information concerning 1856, Participant passcode: 1927394. Prevention, and Agency for Toxic
individuals associated with the grant Net Conference and Web URL: Substances and Disease Registry.
applications, the disclosure of which For Participants: Elaine L. Baker,
would constitute a clearly unwarranted URL: https://www.mymeetings.com/ Director, Management Analysis and Services
invasion of personal privacy. nc/join/. Office, Centers for Disease Control and
Name of Committee: National Institute of Conference number: PW1978421, Prevention.
Biomedical Imaging and Bioengineering Audience passcode: 1927394 and: [FR Doc. 2015–06644 Filed 3–23–15; 8:45 am]
Special Emphasis Panel; P41 BTRC review https://www.mymeetings.com/nc/ BILLING CODE 4163–18–P
(2015/05). join.php?i=PW1978421&p=1927394
Date: May 27, 2015. &t=c.
Time: 9:00 a.m. to 6:00 p.m. Status: Open to the public, limited DEPARTMENT OF HEALTH AND
Agenda: To review and evaluate grant only by the net conference and audio HUMAN SERVICES
applications. phone lines available.
Place: National Institutes of Health, Two Purpose: The committee provides Centers for Disease Control and
Democracy Plaza, Suite 920, 6707 Democracy advice and guidance to the Secretary, Prevention
Boulevard, Bethesda, MD 20892, (Virtual HHS; the Assistant Secretary for Health;
Meeting). and the Director, CDC, regarding the Clinical Laboratory Improvement
Contact Person: Manana Sukhareva, Ph.D., formative research, development, Advisory Committee
Scientific Review Officer, National Institute implementation and evaluation of In accordance with section 10(a)(2) of
of Biomedical Imaging and Bioengineering, evidence-based activities designed to the Federal Advisory Committee Act
6707 Democracy Boulevard, Suite 959, prevent breast cancer (particularly (Pub. L. 92–463), the Centers for Disease
Bethesda, MD 20892, (301) 451–3397,
among those at heightened risk) and Control and Prevention (CDC)
sukharem@mail.nih.gov.
promote the early detection and support announces the following committee
Name of Committee: National Institute of of young women who develop the meeting.
Biomedical Imaging and Bioengineering disease. The advice provided by the Times and Dates:
Special Emphasis Panel; 2015–10 SBIR HD Committee will assist in ensuring 12:30 p.m.–5:00 p.m., April 15, 2014
Review.
scientific quality, timeliness, utility, and 8:30 a.m.–12:00 p.m., April 16, 2014
Date: June 24, 2015.
dissemination of credible appropriate Place: CDC, 1600 Clifton Road NE.,
Time: 10:00 a.m. to 6:00 p.m.
messages and resource materials. Tom Harkin Global Communications
Agenda: To review and evaluate grant
applications.
Matters For Discussion: The agenda Center, Building 19, Auditorium B,
Place: National Institutes of Health, Two will include discussions on the current Atlanta, Georgia 30333.
Democracy Plaza, Suite 920, 6707 Democracy and emerging topics related to breast Status: Open to the public, limited
Boulevard, Bethesda, MD 20892, (Virtual cancer in young women. These may only by the space available. The meeting
Meeting). include risk communication and health room accommodates approximately 100
Contact Person: Ruth Grossman, DDS, education, as well as approaches to people. This meeting will also be
Scientific Review Officer, National Institute increase awareness of clinicians/ Webcast, please see information below.
of Biomedical Imaging and Bioengineering, practitioners regarding topics such as Purpose: This Committee is charged
National Institute of Health, 6707 Democracy breast cancer risk, breast health, with providing scientific and technical
Boulevard, Rm. 960, Bethesda, MD 20892, symptoms, diagnosis, and treatment of advice and guidance to the Secretary of
mstockstill on DSK4VPTVN1PROD with NOTICES

(301) 496–8775, grossmanrs@mail.nih.gov. breast cancer in young women. Health and Human Services (HHS); the
Discussions for formal Assistant Secretary for Health; the
Dated: March 19, 2015.
recommendations will take place. Director, Centers for Disease Control
David Clary, Agenda items are subject to change as and Prevention; the Commissioner,
Program Analyst, Office of Federal Advisory priorities dictate. Food and Drug Administration (FDA);
Committee Policy. Online Registration Required: All and the Administrator, Centers for
[FR Doc. 2015–06698 Filed 3–23–15; 8:45 am] ACBCYW Meeting participants must Medicare and Medicaid Services (CMS).
BILLING CODE 4140–01–P register for the meeting online at least 3 The advice and guidance pertain to

VerDate Sep<11>2014 01:09 Mar 24, 2015 Jkt 235001 PO 00000 Frm 00074 Fmt 4703 Sfmt 4703 E:\FR\FM\24MRN1.SGM 24MRN1

Document Created: 2015-12-18 11:44:49
Document Modified: 2015-12-18 11:44:49

Category		Regulatory Information
Collection		Federal Register
sudoc Class		AE 2.7: GS 4.107: AE 2.106:
Publisher		Office of the Federal Register, National Archives and Records Administration
Section		Notices
Dates		May 27, 2015.
FR Citation		80 FR 15621

80 FR 15621 - National Institute of Biomedical Imaging and Bioengineering; Notice of Closed Meetings

DEPARTMENT OF HEALTH AND HUMAN SERVICESNational Institutes of Health

Federal Register Volume 80, Issue 56 (March 24, 2015)

DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health